Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression

MJF Levy, F Boulle, HW Steinbusch… - …, 2018 - Springer
Depression is a major health problem with a high prevalence and a heavy socioeconomic
burden in western societies. It is associated with atrophy and impaired functioning of cortico …

Depression, antidepressants, and neurogenesis: a critical reappraisal

ND Hanson, MJ Owens, CB Nemeroff - Neuropsychopharmacology, 2011 - nature.com
The neurogenesis hypothesis of depression posits (1) that neurogenesis in the subgranular
zone of the dentate gyrus is regulated negatively by stressful experiences and positively by …

[HTML][HTML] Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors …

AL Pehrson, SC Leiser, M Gulinello, E Dale, Y Li… - European journal of …, 2015 - Elsevier
Although major depressive disorder is primarily considered a mood disorder, depressed
patients commonly present with clinically significant cognitive dysfunction that may add to …

The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment …

M Santos, L Lima, S Carvalho, J Mota-Pereira… - International journal of …, 2023 - mdpi.com
This study aimed to investigate the influence of genetic variants in neuroplasticity-related
genes on antidepressant treatment phenotypes. The BDNF-TrkB signaling pathway, as well …

Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine

B Coutens, A Yrondi, C Rampon, BP Guiard - Psychopharmacology, 2022 - Springer
Major depression (MD) is one of the most common psychiatric disorders worldwide.
Currently, the first-line treatment for MD targets the serotonin system but these drugs, notably …

Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3β, β-catenin, and neurotrophin cascades

A Wada - Journal of pharmacological sciences, 2009 - jstage.jst.go.jp
Mood disorders are not merely attributed to the functional defect of neurotransmission, but
also are due to the structural impairment of neuroplasticity. Chronic stress decreases …

Mechanisms underpinning AMP-activated protein kinase-related effects on behavior and hippocampal neurogenesis in an animal model of depression

T Odaira, O Nakagawasai, K Takahashi, W Nemoto… - …, 2019 - Elsevier
Adenosine monophosphate-activated protein kinase (AMPK) is critical for whole-body
energy metabolism regulation. Recent studies have suggested that physical exercise …

Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor …

J Pascual-Brazo, E Castro, Á Díaz… - International Journal …, 2012 - academic.oup.com
It has been recently suggested that activation of 5-HT4 receptors might exert antidepressant-
like effects in rats after 3 d treatment, suggesting a new strategy for developing faster-acting …

Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication

F Pilar-Cuéllar, R Vidal, A Díaz, E Castro… - Neural …, 2013 - Wiley Online Library
It is widely accepted that changes underlying depression and antidepressant‐like effects
involve not only alterations in the levels of neurotransmitters as monoamines and their …

The absence of 5-HT4 receptors modulates depression-and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice …

J Amigó, A Díaz, F Pilar-Cuéllar, R Vidal, A Martín… - …, 2016 - Elsevier
Preclinical studies support a critical role of 5-HT 4 receptors (5-HT 4 Rs) in depression and
anxiety, but their influence in depression-and anxiety-like behaviours and the effects of …